Stella Xu

Insider Reports History

Entity
Individual
Location
C/O Armo Biosciences, Inc., 575 Chesapeake Drive, Redwood City, CA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stella Xu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. Director Stock Option (right to buy) 15K May 31, 2023 Direct
NextCure, Inc. Director Stock Option (Right to Buy) 14.3K Jun 24, 2021 Direct
Tempest Therapeutics, Inc. Director Stock Option (Right to Buy) 6.64K Jul 1, 2021 Direct

Insider Reports Filed by Stella Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DSGN Design Therapeutics, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
DSGN Design Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
DSGN Design Therapeutics, Inc. Mar 18, 2022 4 -$11.3M 4 Mar 22, 2022 Director
TPST Tempest Therapeutics, Inc. Jul 1, 2021 1 $0 4/A Sep 20, 2021 Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 1 $0 4 Jun 29, 2021 Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 0 $0 3 Jun 29, 2021 Director
NXTC NextCure, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director